Published in Br J Cancer on November 02, 2010
Diet and supplements and their impact on colorectal cancer. J Gastrointest Oncol (2013) 1.27
Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst (2011) 1.16
Mortality of colorectal cancer in Taiwan, 1971-2010: temporal changes and age-period-cohort analysis. Int J Colorectal Dis (2012) 0.91
Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study. BMC Med (2015) 0.89
Parity and risk of colorectal cancer: a dose-response meta-analysis of prospective studies. PLoS One (2013) 0.83
Oral contraceptive use and colorectal cancer in the Nurses' Health Study I and II. Cancer Epidemiol Biomarkers Prev (2015) 0.82
Age at menarche and risk of colorectal cancer: a meta-analysis. PLoS One (2013) 0.80
Contraception in women over 40 years of age. CMAJ (2013) 0.79
The utility of web mining for epidemiological research: studying the association between parity and cancer risk. J Am Med Inform Assoc (2015) 0.78
Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril (2015) 0.77
Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2015) 0.77
Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain. PLoS One (2016) 0.75
Reproductive factors, hormones and colorectal cancer-still unresolved. Br J Cancer (2016) 0.75
Reproductive and menstrual factors and colorectal cancer incidence in the Women's Health Initiative Observational Study. Br J Cancer (2016) 0.75
Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study. Br J Cancer (2016) 0.75
Chemoprevention in patients with genetic risk of colorectal cancers. Colorectal Cancer (2012) 0.75
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ (2007) 3.30
Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control (1994) 2.33
Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst (1980) 2.17
Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 1.78
Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control (1997) 1.75
Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst (1983) 1.70
Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst (1981) 1.19
A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.18
Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control (1994) 1.16
Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev (2005) 1.14
Reproductive factors and colon cancers. Br J Cancer (1990) 1.13
Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control (1992) 1.08
Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut (1995) 1.06
Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol (2007) 1.06
Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update (2009) 1.06
Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control (2007) 1.00
Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer (2009) 1.00
The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer (1998) 0.99
Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control (2005) 0.98
Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer (2008) 0.97
Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology (1997) 0.96
Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol (1993) 0.91
Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res (1991) 0.91
Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control (1997) 0.90
Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2011) 0.88
Oral contraceptive use and risk of colorectal cancer. Epidemiology (1998) 0.87
Reproductive factors, exogenous female hormone use and colorectal cancer risk: the Japan Public Health Center-based Prospective Study. Eur J Cancer Prev (2008) 0.86
Reproductive history and health screening for women and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev (2007) 0.84
Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control (2008) 0.82
Oral contraceptives and colorectal cancer. Dig Liver Dis (2003) 0.82
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
A physical map of the human genome. Nature (2001) 12.39
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Haplotype sharing analysis using mantel statistics. Hum Hered (2005) 6.76
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Consequences of assessment and intervention among elderly people: a three year randomised controlled trial. Br Med J (Clin Res Ed) (1984) 6.00
Physical activity and the risk of breast cancer. N Engl J Med (1997) 5.85
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Comparison of human genetic and sequence-based physical maps. Nature (2001) 4.97
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
Hybridization of labeled RNA to DNA in agarose gels. Nucleic Acids Res (1975) 4.38
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
tRNA genes are found between 16S and 23S rRNA genes in Bacillus subtilis. Nucleic Acids Res (1982) 3.93
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell (1999) 3.84
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
3' end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell (1986) 3.61
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst (2000) 3.55
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev (2000) 3.24
Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem (1995) 3.19
Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother (1991) 3.18
The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J (1997) 3.10
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04